BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27573688)

  • 1. The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism.
    Klein HU; Bennett DA; De Jager PL
    Acta Neuropathol; 2016 Oct; 132(4):503-14. PubMed ID: 27573688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for integrative multi-omic approaches to explore Alzheimer's disease mechanisms.
    Ma Y; Klein HU; De Jager PL
    Brain Pathol; 2020 Sep; 30(5):984-991. PubMed ID: 32654306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invited Review - A 5-year update on epigenome-wide association studies of DNA modifications in Alzheimer's disease: progress, practicalities and promise.
    Smith AR; Wheildon G; Lunnon K
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):641-653. PubMed ID: 32744362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's Disease and Histone Code Alterations.
    Narayan P; Dragunow M
    Adv Exp Med Biol; 2017; 978():321-336. PubMed ID: 28523554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenome-wide association studies in Alzheimer's disease; achievements and challenges.
    van den Hove DLA; Riemens RJM; Koulousakis P; Pishva E
    Brain Pathol; 2020 Sep; 30(5):978-983. PubMed ID: 32654262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Modifications and Alzheimer's Disease.
    Smith RG; Lunnon K
    Adv Exp Med Biol; 2017; 978():303-319. PubMed ID: 28523553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies.
    Lunnon K; Mill J
    Am J Med Genet B Neuropsychiatr Genet; 2013 Dec; 162B(8):789-99. PubMed ID: 24038819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging epigenetics in Alzheimer's disease.
    Lista S; Garaci FG; Toschi N; Hampel H
    Curr Pharm Des; 2013; 19(36):6393-415. PubMed ID: 23432717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer's disease-specific changes in the human cortex.
    Gasparoni G; Bultmann S; Lutsik P; Kraus TFJ; Sordon S; Vlcek J; Dietinger V; Steinmaurer M; Haider M; Mulholland CB; Arzberger T; Roeber S; Riemenschneider M; Kretzschmar HA; Giese A; Leonhardt H; Walter J
    Epigenetics Chromatin; 2018 Jul; 11(1):41. PubMed ID: 30045751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenomics of Alzheimer's disease.
    Bennett DA; Yu L; Yang J; Srivastava GP; Aubin C; De Jager PL
    Transl Res; 2015 Jan; 165(1):200-20. PubMed ID: 24905038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone Modifications in Major Depressive Disorder and Related Rodent Models.
    Deussing JM; Jakovcevski M
    Adv Exp Med Biol; 2017; 978():169-183. PubMed ID: 28523546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease.
    Gjoneska E; Pfenning AR; Mathys H; Quon G; Kundaje A; Tsai LH; Kellis M
    Nature; 2015 Feb; 518(7539):365-9. PubMed ID: 25693568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation in Alzheimer's disease: is it a potential therapeutic target?
    Coppedè F
    Expert Opin Ther Targets; 2021 Apr; 25(4):283-298. PubMed ID: 33843425
    [No Abstract]   [Full Text] [Related]  

  • 15. A machine learning approach to brain epigenetic analysis reveals kinases associated with Alzheimer's disease.
    Huang Y; Sun X; Jiang H; Yu S; Robins C; Armstrong MJ; Li R; Mei Z; Shi X; Gerasimov ES; De Jager PL; Bennett DA; Wingo AP; Jin P; Wingo TS; Qin ZS
    Nat Commun; 2021 Jul; 12(1):4472. PubMed ID: 34294691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer's disease.
    C Silva T; Young JI; Zhang L; Gomez L; Schmidt MA; Varma A; Chen XS; Martin ER; Wang L
    Nat Commun; 2022 Aug; 13(1):4852. PubMed ID: 35982059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.
    Watson CT; Roussos P; Garg P; Ho DJ; Azam N; Katsel PL; Haroutunian V; Sharp AJ
    Genome Med; 2016 Jan; 8(1):5. PubMed ID: 26803900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenomic dissection of Alzheimer's disease pinpoints causal variants and reveals epigenome erosion.
    Xiong X; James BT; Boix CA; Park YP; Galani K; Victor MB; Sun N; Hou L; Ho LL; Mantero J; Scannail AN; Dileep V; Dong W; Mathys H; Bennett DA; Tsai LH; Kellis M
    Cell; 2023 Sep; 186(20):4422-4437.e21. PubMed ID: 37774680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.
    Talwar P; Sinha J; Grover S; Rawat C; Kushwaha S; Agarwal R; Taneja V; Kukreti R
    Mol Neurobiol; 2016 Sep; 53(7):4833-64. PubMed ID: 26351077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent studies on cellular and molecular mechanisms in Alzheimer's disease: focus on epigenetic factors and histone deacetylase.
    Dubey H; Gulati K; Ray A
    Rev Neurosci; 2018 Mar; 29(3):241-260. PubMed ID: 29397389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.